BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 11426549)

  • 21. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
    Einsiedel HG; von Stackelberg A; Hartmann R; Fengler R; Schrappe M; Janka-Schaub G; Mann G; Hählen K; Göbel U; Klingebiel T; Ludwig WD; Henze G
    J Clin Oncol; 2005 Nov; 23(31):7942-50. PubMed ID: 16258094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation.
    Seriu T; Yokota S; Nakao M; Misawa S; Takaue Y; Koizumi S; Kawai S; Fujimoto T
    Leukemia; 1995 Apr; 9(4):615-23. PubMed ID: 7723394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
    Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse.
    Coustan-Smith E; Gajjar A; Hijiya N; Razzouk BI; Ribeiro RC; Rivera GK; Rubnitz JE; Sandlund JT; Andreansky M; Hancock ML; Pui CH; Campana D
    Leukemia; 2004 Mar; 18(3):499-504. PubMed ID: 14981525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of primary clonogenic blasts from acute lymphoblastic leukemia patients to an activated cyclophosphamide, viz., mafosfamide.
    Uckun FM; Chandan-Langlie M; Dockham PA; Aeppli D; Sladek NE
    Leuk Lymphoma; 1994 May; 13(5-6):417-28. PubMed ID: 8069187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dynamically monitoring minimal residual disease in acute leukemia after complete remission by multiparameter flow cytometry and its relation with prognosis].
    Sun NN; Gan SL; Sun H; Zhang QT; Liu YF; Xie XS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):339-42. PubMed ID: 23628028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
    zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
    Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry.
    Sievers EL; Lange BJ; Buckley JD; Smith FO; Wells DA; Daigneault-Creech CA; Shults KE; Bernstein ID; Loken MR
    J Natl Cancer Inst; 1996 Oct; 88(20):1483-8. PubMed ID: 8841024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated bone relapse during hematologic remission in childhood acute lymphoblastic leukemia: report of a metatarsal relapse and review of the literature.
    Murray JC; Gmoser DJ; Barnes DA; Oshman D; Hawkins HK; Gresik MV; Dreyer ZE
    Med Pediatr Oncol; 1994; 23(2):153-7. PubMed ID: 8202041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation resistance of primary clonogenic blasts from children with acute lymphoblastic leukemia.
    Uckun FM; Aeppli D; Song CW
    Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):899-906. PubMed ID: 8244821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoblast colony-culture assay in acute lymphoblastic leukemia: a quantitative approach.
    Hong RL; Shen SW; Lin MT; Tien HF; Yang CH; Chen YC
    Leuk Res; 1993 May; 17(5):463-70. PubMed ID: 8501973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia.
    Coustan-Smith E; Behm FG; Sanchez J; Boyett JM; Hancock ML; Raimondi SC; Rubnitz JE; Rivera GK; Sandlund JT; Pui CH; Campana D
    Lancet; 1998 Feb; 351(9102):550-4. PubMed ID: 9492773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiobiological features of fresh leukemic bone marrow progenitor cells in acute lymphoblastic leukemia.
    Uckun FM; Song CW
    Cancer Res; 1988 Oct; 48(20):5788-95. PubMed ID: 3262412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between "molecular" and clinical relapse?
    Aricò M; Germano G; del Giudice L; Ziino O; Locatelli F; Basso G
    Haematologica; 2002 Apr; 87(4):ELT19. PubMed ID: 11940504
    [No Abstract]   [Full Text] [Related]  

  • 36. Post chemotherapy blood and bone marrow regenerative changes in childhood acute lymphoblastic leukemia a prospective study.
    Kushwaha R; Kumar A; Aggrawal K; Nigam N; Kumar A
    Indian J Pathol Microbiol; 2014; 57(1):72-7. PubMed ID: 24739836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse.
    Biondi A; Yokota S; Hansen-Hagge TE; Rossi V; Giudici G; Maglia O; Basso G; Tell C; Masera G; Bartram CR
    Leukemia; 1992 Apr; 6(4):282-8. PubMed ID: 1316978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of occult leukemic cells in the autologous bone marrow graft of a patient with T-cell acute lymphoblastic leukemia by a highly specific and sensitive assay.
    Bregni M; Siena S; Subar M; Villa S; Bonadonna G; Dalla-Favera R; Gianni AM
    Haematologica; 1989; 74(1):11-4. PubMed ID: 2498173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia.
    Coustan-Smith E; Sancho J; Hancock ML; Razzouk BI; Ribeiro RC; Rivera GK; Rubnitz JE; Sandlund JT; Pui CH; Campana D
    Blood; 2002 Oct; 100(7):2399-402. PubMed ID: 12239148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.